Document Detail

Resuscitation after prolonged cardiac arrest: effects of cardiopulmonary bypass and sodium-hydrogen exchange inhibition on myocardial and neurological recovery.
MedLine Citation:
PMID:  21397513     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To determine if cardiopulmonary bypass (CPB), together with inhibition of the sodium-hydrogen exchanger (NHE), limits myocardial and neurological injury and improves recovery after prolonged (unwitnessed) cardiac arrest (CA), as NHE inhibition improved recovery after deep hypothermic circulatory arrest.
METHODS: Twenty-seven pigs (31-39 kg) underwent 15 min of prolonged (no-flow) CA followed by 10 min of cardiopulmonary resuscitation-advanced life support (CPR-ALS). Subjects with restoration of spontaneous circulation (ROSC) during CPR-ALS received either no drug (n=6) or an inhibitor of the NHE (HOE-642; n=5). In the 16 unsuccessfully resuscitated animals, peripheral normothermic CPB was instituted, and either no drug (n=9) or similar HOE-642 (n=7) therapy started. Hemodynamic data, a species-specific neurological deficit score (0=normal to 500=brain death), and mortality were recorded at 24h, and biochemical variables of organ injury measured.
RESULTS: CPR-ALS restored ROSC in 41% (11/27) of animals, but was unsuccessful in 59% (16/27) that required CPB. Without CPB, HOE-642 increased cardiac index and decreased vascular resistance; with CPB, HOE-642 caused higher pump flows (3.4±0.6 l min(-1)m(-2) vs 2.5±0.7 l min(-1)m(-2); p<0.001) and higher post-arrest cardiac index; but animals required more vasopressors (p=0.019) from drug-induced vasodilation. No differences between biochemical markers of oxidative and organ injury and overall 24-h mortality (20%) were found between groups. Neurological score was improved at 24h compared with 4h only after HOE-642 treatment with (150±34 vs 220±43; p=0.003) or without CPB (162±39 vs 238±48; p≤0.001), but failed to reach statistical difference with respect to the untreated group.
CONCLUSIONS: CPB is an effective resuscitative tool to treat prolonged CA but there is limited improvement of neurological function. NHE inhibition augments cardiac and neurological function, but its effect was less pronounced than in other studies.
Oliver J Liakopoulos; Nikola Hristov; Gerald D Buckberg; Jonathan Triana; Georg Trummer; Bradley S Allen
Related Documents :
1686433 - Malignant arrhythmias in relation to values of serum potassium in patients with acute m...
1384003 - Three decades of antiarrhythmic therapy.
18848143 - Cardiac uptake of minocycline and mechanisms for in vivo cardioprotection.
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural     Date:  2011-03-11
Journal Detail:
Title:  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery     Volume:  40     ISSN:  1873-734X     ISO Abbreviation:  Eur J Cardiothorac Surg     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-09-19     Completed Date:  2012-02-16     Revised Date:  2013-06-30    
Medline Journal Info:
Nlm Unique ID:  8804069     Medline TA:  Eur J Cardiothorac Surg     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  978-84     Citation Subset:  IM    
Copyright Information:
Copyright © 2011. Published by Elsevier B.V.
Department of Surgery, Division of Cardiothoracic Surgery, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiopulmonary Bypass / methods*
Cardiopulmonary Resuscitation / methods*
Combined Modality Therapy
Disease Models, Animal
Guanidines / pharmacology,  therapeutic use
Heart Arrest / complications,  physiopathology,  therapy*
Hemodynamics / drug effects,  physiology
Myocardial Reperfusion Injury / prevention & control
Nervous System Diseases / etiology,  prevention & control*
Seizures / etiology,  therapy
Sodium-Hydrogen Antiporter / antagonists & inhibitors*
Sulfones / pharmacology,  therapeutic use
Sus scrofa
Treatment Outcome
Grant Support
R01-HL-71729-04/HL/NHLBI NIH HHS
Reg. No./Substance:
0/Guanidines; 0/Sodium-Hydrogen Antiporter; 0/Sulfones; 7E3392891K/cariporide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Calculation of true coincidence summing corrections for extended sources with EFFTRAN.
Next Document:  Functional outcome of anatomic correction of corrected transposition of the great arteries.